Clearwater Capital Advisors, LLC Immunity Bio, Inc. Transaction History
Clearwater Capital Advisors, LLC
- $973 Million
- Q3 2024
A detailed history of Clearwater Capital Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Clearwater Capital Advisors, LLC holds 482,549 shares of IBRX stock, worth $2.17 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
482,549
Previous 482,549
-0.0%
Holding current value
$2.17 Million
Previous $3.05 Million
41.29%
% of portfolio
0.18%
Previous 0.34%
Shares
10 transactions
Others Institutions Holding IBRX
# of Institutions
202Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$75.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$51.3 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$38.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$17.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$10.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.8B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...